These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3978593)

  • 1. Chromosomal analysis of bladder cancer: technical aspects.
    Smeets W; Pauwels R; Geraedts J
    Cancer Genet Cytogenet; 1985 Apr; 16(3):259-68. PubMed ID: 3978593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic analysis in urothelial cell carcinoma.
    Pauwels RP; Smeets WW; Geraedts JP; Debruyne FM
    J Urol; 1987 Feb; 137(2):210-5. PubMed ID: 3468265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal analysis of bladder cancer. II. A practical method.
    Smeets W; Pauwels R; Laarakkers L; Debruyne F; Geraedts J
    Cancer Genet Cytogenet; 1987 Nov; 29(1):23-7. PubMed ID: 3664446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic analysis of 62 transitional cell bladder carcinomas.
    Granberg-Ohman I; Tribukait B; Wijkström H
    Cancer Genet Cytogenet; 1984 Jan; 11(1):69-85. PubMed ID: 6690024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
    Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
    Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of marker chromosomes in relation to histologic grade in bladder cancer.
    Milasin J; Mićić M; Mićić S; Diklić V
    Cancer Genet Cytogenet; 1989 Oct; 42(1):135-42. PubMed ID: 2790741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
    Panani AD; Ferti AD; Raptis SA; Roussos C
    Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of marker chromosomes in bladder tumor.
    Vanni R; Scarpa RM; Nieddu M; Usai E
    Urol Int; 1986; 41(6):403-6. PubMed ID: 3824694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
    Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
    Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of lymphocyte culture media on the number of metaphases and chromosome band resolution.
    Chomik P; Gryzinska M; Batkowska J; Jezewska-Witkowska G; Kocki J
    Postepy Hig Med Dosw (Online); 2016 Oct; 70(0):1095-1100. PubMed ID: 27892892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal analysis of bladder cancer. III. Nonrandom alterations.
    Smeets W; Pauwels R; Laarakkers L; Debruyne F; Geraedts J
    Cancer Genet Cytogenet; 1987 Nov; 29(1):29-41. PubMed ID: 3311350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal rearrangements in bladder cancer.
    Gibas Z; Sandberg AA
    Urology; 1984 Mar; 23(3 Suppl):3-9. PubMed ID: 6367193
    [No Abstract]   [Full Text] [Related]  

  • 14. Spectral karyotyping study of chromosome abnormalities in human leukemia.
    Zhao L; Hayes K; Khan Z; Glassman A
    Cancer Genet Cytogenet; 2001 Jun; 127(2):143-7. PubMed ID: 11425454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromosomal analysis of primary superficial tumors of the bladder].
    Martorana G; Giberti C; de Ferrari M; Ottaggio L; Giuliani L
    J Urol (Paris); 1983; 89(7):489-92. PubMed ID: 6655279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unstable chromosome aberrations in bladder and renal cell carcinoma.
    Moriyama-Gonda N; Sumi H; Shiina H; Himeno Y; Ishibe T
    Cancer Genet Cytogenet; 1991 Oct; 56(1):65-72. PubMed ID: 1747870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifty-three month persistence of ring chromosome in noninvasive bladder carcinoma.
    Falor WH; Ward RM
    Acta Cytol; 1976; 20(3):272-5. PubMed ID: 1064279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivative 11 marker chromosome in bladder carcinoma.
    Vanni R; Peretti D; Scarpa RM; Usai E
    Cancer Genet Cytogenet; 1985 Apr; 16(4):289-95. PubMed ID: 3842798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
    Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
    Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A squamous cell bladder carcinoma with karyotypic abnormalities reminiscent of transitional cell carcinoma.
    Lundgren R; Elfving P; Heim S; Kristoffersson U; Mandahl N; Mitelman F
    J Urol; 1989 Aug; 142(2 Pt 1):374-6. PubMed ID: 2746756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.